Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PDI, a provider of commercialization services to the biopharmaceutical industry, has announced the signing of a four-year agreement with Novartis Pharmaceuticals, whereby PDI will deploy a field force to promote a Novartis branded product in the US.
Subscribe to our email newsletter
PDI currently intends to deploy approximately 100 full-time equivalent sales representatives who will call upon physicians nationwide. Novartis will continue to be responsible for manufacturing, regulatory, medical, clinical development, pricing, managed care contracting, and distribution for the product. The agreement is subject to early termination under certain circumstances.
Michael Marquard, PDI’s CEO, said: This is the type of opportunity we envisioned when we established our new product commercialization business unit. We entered into this agreement with Novartis following considerable due diligence, including extensive market research and demand forecasting. We are looking forward to leveraging our sales and marketing expertise to support this important opportunity.